Hennepin Healthcare Research Institute
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hennepin Healthcare Research Institute sits in the top decile of US sponsors by registered trial count (#328 of 15,742 sponsors by registered trial count).
Hennepin Healthcare Research Institute: 63 sponsored US clinical trials, 4 recruiting.
Hennepin Healthcare Research Institute sponsors 63 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 49 completed. 12 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Acute Coronary Syndrome, with 4 trials.
Top-decile sponsor footprint
Hennepin Healthcare Research Institute ranks in the top decile of sponsors by registered trial count (#328 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
49 of 55 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
63 total, page 1 of 2
Social Support Counseling Intervention for Kidney Transplant Candidates
NCT06147076
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
NCT06514547
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
NCT05879302
International Device Assisted Controlled Sequential Elevation CPR Registry
NCT05588024
MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.
NCT05853042
Post Acute Cardiac Event Smoking (PACES) Study
NCT03413423
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
NCT03214029
Magnesium Sulfate in Pediatric Burn Dressing Changes
NCT07126795
Diabetes Homelessness Medication Support Program in Spanish
NCT05819749
Diabetes Homeless Medication Support
NCT05258630
Assessing Accuracy of the Freestyle Libre Pro Glucose Monitoring in Patients With Diabetes in a Critical Care Setting
NCT06800365
Diabetes Homeless Medication Support Single Arm Treatment Development Trial
NCT04678284
High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department
NCT04398316
Safe Emergency Department DIscharGE Rate (SEIGE)
NCT04772157
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction
NCT04280926
Pilot Social Support Counseling Intervention for Kidney Transplant Candidates
NCT04363515
Healthy Heart Habits
NCT04158219
Jail-Based Use of Smoking Cessation Treatment Study
NCT03799315
Olanzapine Versus Midazolam for Agitation
NCT03899506
Drug Order for Rapid Sequence Intubation
NCT03420950
Peak Expiratory Flow Rate for Emergency Department Management of Acute Asthma Exacerbation
NCT03420651
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
NCT03319966
The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients
NCT03938584
Ketamine Versus Midazolam for Prehospital Agitation
NCT03554915
Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation
NCT03211897
Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
NCT03001323
Bougie Use in Emergency Airway Management
NCT02902146
Non-rebreather at Flush Rate Compared to Bag Valve Mask With Assist
NCT02841592
Neuroimaging and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
NCT02771106
Using "Store and Forward" Tele-health as an Adjunct to Traditional Outpatient or Home Health Physical Therapy
NCT02659280
Emergency Department Cardiac Ultrasound
NCT02719509
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355
Transvaginal Pelvic Ultrasound in the ED
NCT02547857
Capacity to Consent in Acutely Intoxicated Emergency Department Patients
NCT02885532
Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease
NCT02339415
ED Management of Severe Hyperglycemia: A Clinical Trial
NCT02478190
Juice Preference in the Emergency Department
NCT02506478
Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial
NCT02049307
Moderate Versus Deep Procedural Sedation With Propofol in the Emergency Department
NCT02404610
Inpatient Diabetes on Corticosteroids
NCT01970241
Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes
NCT02060760
Ketamine Versus Etomidate for Rapid Sequence Intubation
NCT01823328
Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department
NCT01747824
Use of MigraineBoxTM Head and Neck Cooling Bath for Treatment of Primary Headache in the Emergency Department
NCT01977001
Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services
NCT01783223
The Use of the USCOM Device in Addition to Cardiac Ultrasound in Patients Undergoing Treatment for Undifferentiated Shock
NCT01981629
Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management
NCT01710891
Effect of Modality on Discharge Instruction in Patients Receiving Outpatient Antibiotic Prescriptions From the Emergency Department
NCT01775969
Randomized Clinical Trial of Propofol, 1:1 and 4:1 Combination of Propofol and Ketamine for Procedural Sedation
NCT01260662
Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department
NCT02101424
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 4 | 12 |
Where Hennepin Healthcare Research Institute enrollment is open (later-stage tilt)
4 recruiting of 63 indexed (6% open); 49 completed (78%).
Phase mix: 12 late (III/IV) vs 7 early (I/II) (later-stage heavy).
Top condition: Acute Coronary Syndrome (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hennepin Healthcare Research Institute: open-pipeline peers nationwide
Peers matched on 63 registered trials and 6% open enrollment, not the therapeutic-area sidebar.
Hennepin Healthcare Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 63 trials (± recruiting share)
- Actelion · 63 trials · 0% recruiting
- United Therapeutics · 63 trials · 8% recruiting
- University of Oregon · 63 trials · 16% recruiting
- Cephalon · 64 trials · 0% recruiting
Sponsors near 6% open enrollment (± trial volume)
- Biogen · 6% recruiting · 334 trials
- Albert Einstein Healthcare Network · 6% recruiting · 48 trials
- Altimmune · 6% recruiting · 16 trials
- Bassett Healthcare · 6% recruiting · 16 trials
Related
What to do with this Hennepin Healthcare Research Institute page
63 registered trials is a research-attention snapshot, not an endorsement of Hennepin Healthcare Research Institute or any single study.
- 4 of Hennepin Healthcare Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute Coronary Syndrome is the condition Hennepin Healthcare Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Coronary Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hennepin Healthcare Research Institute pipeline card: 63 registered trials from official public datasets.Report a data error.